MARKET

JYNT

JYNT

The Joint
NASDAQ

Real-time Quotes | Nasdaq Last Sale

25.83
-0.94
-3.51%
After Hours: 25.83 0 0.00% 16:00 11/23 EST
OPEN
27.00
PREV CLOSE
26.77
HIGH
27.00
LOW
25.75
VOLUME
137.06K
TURNOVER
--
52 WEEK HIGH
27.00
52 WEEK LOW
7.67
MARKET CAP
362.68M
P/E (TTM)
98.21
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Joint Q3 EPS $0.11 Beats $0.02 Estimate, Sales $15.41M Beat $13.70M Estimate
Joint (NASDAQ:JYNT) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.02 by 450 percent. This is a 175 percent increase over earnings of $0.04 per share from the same period
Benzinga · 11/05 21:48
Joint EPS beats by $0.08, beats on revenue
Joint (JYNT): Q3 GAAP EPS of $0.11 beats by $0.08.Revenue of $15.4M (+21.0% Y/Y) beats by $1.7M.Press Release
Seekingalpha · 11/05 21:38
Joint Corp (JYNT) Has Fallen 10% in Last One Year, Underperforms Market
If you are looking for the best ideas for your portfolio you may want to consider some of Artko Capital's top stock picks. Artko Capital, an investment management firm, is bearish on Joint Corp (NASDAQ:JYNT) stock. In its Q2 2019 investor letter – you can download a copy here – the firm discussed
Insider Monkey · 09/18 16:12
Top Ranked Momentum Stocks to Buy for September 1st
Top Ranked Momentum Stocks to Buy for September 1st
Zacks · 09/01 14:50
LD Micro - 360 Companies - Set to Present this Week
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
ACCESSWIRE · 08/31 22:00
Joint Corp's Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in The Joint Corp.
Zacks · 08/28 16:33
Top Ranked Momentum Stocks to Buy for August 28th
Top Ranked Momentum Stocks to Buy for August 28th
Zacks · 08/28 14:06
Joint EPS beats by $0.10, beats on revenue
Joint (NASDAQ:JYNT): Q2 GAAP EPS of $0.01 beats by $0.10. Revenue of $12.59M (+12.7% Y/Y) beats by $2.25M. Press Release
seekingalpha · 08/07 01:17
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of JYNT. Analyze the recent business situations of The Joint through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average JYNT stock price target is 27.33 with a high estimate of 31.00 and a low estimate of 25.00.
EPS
Institutional Holdings
Institutions: 126
Institutional Holdings: 11.56M
% Owned: 82.29%
Shares Outstanding: 14.04M
TypeInstitutionsShares
Increased
30
363.29K
New
17
-19.93K
Decreased
30
726.89K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.90%
Healthcare Providers & Services
+0.72%
Key Executives
President/Chief Executive Officer/Director
Peter Holt
Chief Financial Officer
Jake Singleton
Lead Director/Independent Director
Matthew Rubel
Chief Compliance Officer
James Edwards
Independent Director
James Amos
Independent Director
Ronald DaVella
Independent Director
Suzanne Decker
Independent Director
Abe Hong
Independent Director
Glenn Krevlin
Independent Director
Ronald Davella
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About JYNT
The Joint Corp develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. The Company has over 425 franchised, company-owned, or managed clinics in operation in over 30 states. In addition to its operating clinics, the Company has granted franchises either directly or through its regional developers for an additional over 170 clinics. The Company offers a range of membership and wellness packages. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Joint Corp stock information, including NASDAQ:JYNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JYNT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading JYNT stock methods without spending real money on the virtual paper trading platform.